(Q45057390)

English

A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex) in patients with alcohol dependence (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

0 references

author name string

Bankole A Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Nassima Ait-Daoud

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Henri-Jean Aubin

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Wim Van Den Brink

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Richard Guzzetta

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

John Loewy

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Bernard Silverman

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Elliot Ehrich

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1356-1361

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Naltrexone in the treatment of alcoholism: a clinical review

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Drug therapy for alcohol dependence

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000139823.30096.52

21 January 2018

Identifiers

10.1097/01.ALC.0000139823.30096.52

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

release_qa35lmcsffgp7g53ectzfwgygq

1 reference

https://api.fatcat.wiki/v0/release/qa35lmcsffgp7g53ectzfwgygq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45057390&oldid=2064320954"